No Detail Found!

Prevalence and Rate of Seroconversion of Hepatitis C in Hemodialysis Patients.

Author(s)
Salman T. Shafi Department of Nephrology, Services Hospital and Postgraduate Medical Institute, Lahore, Pakistan
Rizwan-Ul-Haq Department of Nephrology, Services Hospital and Postgraduate Medical Institute, Lahore, Pakistan
Tahir Shafi Department of Nephrology, Services Hospital and Postgraduate Medical Institute, Lahore, Pakistan
Abstract
Hemodialysis patients are at high risk of acquiring hepatitis C infection. Prevalence of anti HCV antibodies was determined by 3rd generation ELISA among 122 (69 males, 53 females) patients undergoing hemodialysis. Out of 122 patients, 69 (56.6%) patients were found to be anti HCV positive. Anti HCV antibodies were positive in 24 (19.7%) patient before starting hemodialysis. During hemodialysis, 45 (45.9%) patients became anti HCV positive. Mean duration of dialysis of sero-positive patients was 29.3±24.8 months, where as that of sero-negative patients was 14.7±19.8 months. This difference was statistically significant. Frequency of sero-positivity was found to be 4.5%, 22.6%, 46.3%, 66%, 74.1% and 89.5% after 6 months, 1 year, 2 years, 3 years, 4 years and 5 years of hemodialysis respectively. Annual rate of sero-conversion was found to be 32.2%, 28.4% and 34.4% in years 2000, 2001 and 2002 respectively. We recommend strict application of universal infection control measures to limit transmission of hepatitis C in hemodialysis units.
Publication Details
Page(s) 19-22
DOI DOI not available
Published Journal: Proceedings of sheikh zayed postgraduate medical institute, Volume: 17, Issue: 1, Year: 2003

Request the full text from PASTIC

0

Citations

0

Downloads

167

Views